The FDA has identified concerns involving: Potential immunogenicity Peptide-related impurities Limited safety information for proposed routes of administration Insufficient information to determine whether compounded BPC-157 may cause harm in humans This does not prove that every patient who receives BPC-157 will experience a serious adverse event
In the endosome it blocks entry of viral RNA (19) by not allowing the endosome pH to acidify, thereby preventing the acidic-pH-dependent conformational change required by the coronavirus spike protein to fuse with the endosome membrane (25, 26))
Maquart and colleagues reported stimulation of collagen synthesis in fibroblast cultures by GHK-Cu, while later work connected GHK-Cu to matrix remodeling enzymes and inhibitors [4], [5]
Its typically administered through IV or IM injections for fast absorption and optimal effectiveness
All injections were performed under general anesthesia using ultrasound guidance by a trained physiatrist under sterile conditions
doi:10.1002/poc.861 Caffieri S, Miolo G, Seraglia R et al (2007) Photoaddition of fluphenazine to nucleophiles in peptides and proteins